About US
Contact us
-
In Repatha patent feud, Supreme Court asks United States' top lawyer to weigh Amgen's appealThe U.S. Supreme Court is breaking out the big guns to help make sense of Amgen and Sanofi's long-running PCSK9 patent feud. “The Solicitor General is invited to file a2022/4/22
-
BeiGene nabs another PD-1 approval in China. Can partner Novartis carry the success to US and Europe?With the lack of success of its PD-1/L1 candidate spartalizumab, Novartis last year decided to buy its way into the arena. So it struck a deal with BeiGene of China, paying $650 million up front and2022/4/19
-
Could Pfizer's Paxlovid or other antivirals help cure long COVID?While the biopharmaceutical industry has been quick to develop vaccines, antibodies and antiviral remedies to combat the coronavirus, one area that has remained elusive for researchers is long COVID.2022/4/19
-
The mysterious case of Viatris and the missing insulin label deepensViatris and the case of the missing insulin label is getting a second act. Mylan Pharmaceuticals, now flying the Viatris banner, said Tuesday that it wasrecallingone lot of insulin glargine inj2022/4/14
-
AACR: Novartis aims to keep canakinumab's early lung cancer hopes alive despite metastatic failureWhen Novartis failed in an attempt to repurpose Ilaris for metastatic non-small cell lung cancer (NSCLC), the Swiss pharma played up signs that it said supported continued exploration of the med in e2022/4/14
-
GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contractsAs CureVac and GlaxoSmithKline mulligan with a second-generation COVID-19 vaccine, the partners have signed on for a German pandemic contingency plan to earmark mRNA production capacity for years to2022/4/12
-
Lilly goes down under to find a partner for failed cancer drug Lartruvo, licensing certain rights to Telix for $5MEli Lilly has pulled failed cancer drug Lartruvo off the scrap heap andlicensedcertain rights to Australian biotech Telix for a mere $5 million. Telix, which is based in Melbourne, will give La2022/4/12
-
Alnylam founder Maraganore snags $10.2M pay in his farewell year, as new CEO Greenstreet grabs $8.6MJohn Maraganore, Ph.D., officially stepped down as CEO of Alnylam Pharmaceuticals at the end of 2021. In his last year leading the RNA interference specialist, the former helmsmangot $10.18 million i2022/4/8
-
A seasonal COVID-19 booster shot? Don't count on it in the U.S. or EuropePeople in the U.S. and Europe hoping to receive COVID-19 vaccine booster shots every four to six months are in for a rude awakening. On Wednesday, experts on both sides of the Atlantic to2022/4/8
-
Novartis gets FDA nod to begin making Zolgensma in North CarolinaNovartis can begin producing its spinal muscular atrophy (SMA) gene therapy, Zolgensma, at its North Carolina plant following FDA'sapproval for amanufacturing licenseat the site. The regulatory2022/4/6